Phenylbutyrate attenuates the expression of Bcl-XL, DNA-PK, caveolin-1, and VEGF in prostate cancer cells

Neoplasia

Volumn 3, Issue 4, 2001, Pages 331-338

  Goh, Meidee ^a   Chen, Feng ^a   Paulsen, Michelle T ^a   Yeager, Ann M ^a   Dyer, Erica S ^a   Ljungman, Mats ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b 4306 CCGC   (United States)

Author keywords

Angiogenesis; Apoptosis; Histone deacetylase inhibitor; Invasion; Radiosensitizer

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; CAVEOLIN 1; COMPLEMENTARY DNA; DNA DEPENDENT PROTEIN KINASE; GENE PRODUCT; HISTONE DEACETYLASE INHIBITOR; PROTEIN BCL X; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIOSENSITIZATION; WESTERN BLOTTING;

EID: 0034871794     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900165     Document Type: Article

References (60)

1. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate
2. Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo
3. Effects of sodium butyrate, a new pharmacological agent, on cells in cultures
4. The expression of a small fraction of cellular genes is changed in response to histone hyper-acetylation
5. L), ID1, ID2, ID3, CRABP, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells
6. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
7. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: Comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer
8. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line
9. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation
10. Upregulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells
11. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition
12. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells
13. Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells
14. Bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however, overexpression of bcl-2 does not protect against bak-mediated apoptosis
15. Phenylbutyrate-induced apoptosis and differential expression of Bcl-2, Bax, p53 and Fas in human prostate cancer cell lines
16. L expression in human fibroblasts and acts in synergy with ionizing radiation to induce apoptosis
17. Butyrate is a potent inhibitor of urokinase secretion by normal colonic epithelium in vitro
18. Inhibitory effects of phenylbutyrate on the proliferation, morphology, migration and invasiveness of malignant glioma cells
19. Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers
20. Phase I study of the differentiation agent phenylbutyrate in patients with cancer
21. Modifying histones to tame cancer: Clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors
22. Role of short-chain fatty acids in the prevention of colorectal cancer
23. Dietary butyrate inhibits NMU-induced mammary cancer in rats
24. Blockage of RNA polymerase as a possible trigger for UV light-induced apoptosis
25. L through caspase interaction
26. What's up and down with histone deacetylation and transcription?
27. Inhibition of histone deacetylases: A new strategy to target epigenetic modifications for anticancer treatment
28. Expression and upregulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate
29. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect
30. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line
31. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy
32. Elevated expression of caveolin is associated with prostate and breast cancer
33. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
34. G(1) phase growth arrest and induction of p21 (Waf1/Cip1/Sdi1) in IB3-1 cells treated with 4-sodium phenylbutyrate
35. Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: Structure-function analysis
36. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells
37. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death
38. Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells
39. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer
40. Stabilization of wild-type p53 by hypoxia-inducible factor 1 alpha
41. Regulation of the DNA-dependent protein kinase (DNA-PK) activity in eukaryotic cells
42. p21 (Waf1) is required for butyrate-mediated growth inhibition of human colon cancer cells
43. Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrate
44. Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine
45. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis?
46. Bcl-2 family members and the mitochondria in apoptosis
47. Bcl-x(L) is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis
48. L in prostate cancer cells: Effects of overexpression and down-regulation on chemosensitivity
49. An informatics approach identifying markers of chemosensitivity in human cancer cell lines
50. Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents
51. Inhibition of repair of X-ray-induced DNA double-strand breaks in human lymphocytes exposed to sodium butyrate
52. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker
53. Role of urokinase receptor and caveolin in regulation of integrin signaling
54. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells
55. Invasion of selectively permeable sea urchin embryo basement membranes by metastatic tumor cells, but not by their normal counterparts
56. Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma
57. Inhibition of human endothelial cell proliferation in vitro in response to n-butyrate and propionate
58. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation
59. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin
60. Combined effects of angiostatin and ionizing radiation in antitumour therapy